Immune discovery set to boost cancer therapies, study suggests
Cancer therapies that use immune cells to trigger the body to attack tumours could be improved by a molecule that boosts their function.
May 28, 2019
0
117
Cancer therapies that use immune cells to trigger the body to attack tumours could be improved by a molecule that boosts their function.
May 28, 2019
0
117
Why doesn't the same treatment work in the same way for every patient? How can a drug's performance be optimised without causing side effects due to an excessive dosage? In an attempt to answer these questions, researchers ...
May 21, 2019
0
3
Dr. Tim Fenton, an expert in cancer research at the University, says the announcement of new strategies to overcome the evolution of drug resistance in tumours could dramatically increase the effectiveness of cancer therapies.
May 17, 2019
0
4
Glioblastoma is the most prevalent and also the most lethal type of brain tumour in adults, with no curative treatment currently available. Glioblastomas cannot be surgically completely excised, as the tumour cells are adept ...
May 10, 2019
0
4
Nearly 90 percent of all cancer patient deaths are due to metastasis. A study from Uppsala University shows that a process that allows the cells to metastasise is aided by the synthesis of new ribosomes, the cell components ...
May 8, 2019
0
0
Scientists have identified a gene mutation in the tumours of men with prostate cancer that is linked to very poor survival—and which could be used to pick out patients for more intensive treatment.
May 6, 2019
0
49
Brain tumours are the leading cause of non-accidental death in children in Canada, but little is known about when these tumours form or how they develop. Researchers have recently identified the cells that are thought to ...
May 1, 2019
0
34
A comparison of three types of radiotherapy for children's brain tumours suggests that a type of proton therapy called pencil beam scanning offers the best hope of preserving cognitive functions.
Apr 30, 2019
0
1
Cervical cancer negative for the human papilloma virus (HPV) is rare but more aggressive. It is more frequently diagnosed at advanced stages, with more metastasis and reduced survival. These are the conclusions of a study ...
Apr 18, 2019
0
1
Cancers can make themselves harder for new immunotherapies to see by 'changing their spots' - and switching off a key molecule on the surface of cells that is otherwise recognised by treatment.
Apr 15, 2019
1
17